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Engulfment of apoptotic cells by phagocytes is impor-
tant throughout development and adult life [1, 2].When
phagocytes engulf apoptotic cells, they increase their
cellular contents including cholesterol and phospho-
lipids, but how the phagocytes respond to this in-
creased load is poorly understood. Here, we identify
one type of a phagocyte response, wherein the recog-
nition of apoptotic cells triggers enhanced cholesterol
efflux (to apolipoproteinA-I) frommacrophages. Phos-
phatidylserine (PS) exposed on apoptotic cells was
necessary and sufficient to stimulate the efflux re-
sponse. A major mechanism for this enhanced efflux
by macrophages was the upregulation of the mRNA
and protein for ABCA1, a membrane transporter inde-
pendently linked to cholesterol efflux aswell as engulf-
ment of apoptotic cells [3, 4]. This increase in phago-
cyte ABCA1 levels required the function of nuclear
receptor LXRa/b, a known regulator of cholesterol
homeostasis in humans and mice [5]. Taken together,
these data reveal a ‘‘homeostatic program’’ initiated
in phagocytes that include a proximal membrane
signaling event initiated by PS recognition, a down-
stream signaling event acting through nuclear recep-
tors, and an effector arm involving upregulation of
ABCA1, in turn promoting reverse cholesterol trans-
port from the phagocytes. These data also have impli-
cations for macrophage handling of contents derived
from apoptotic versus necrotic cells in atherosclerotic
lesions [6].
Results and Discussion
Distribution of Apoptotic Cell-Derived Cholesterol
within the Phagocyte
We first addressed whether cholesterol derived from an
engulfed apoptotic cell becomes distributed within the
phagocyte or might be preferentially removed from the
phagocyte. Fluorescent dansyl-cholesterol-labeled
*Correspondence: ylmarcel@ottawaheart.ca (Y.L.M.), ravi@virginia.
edu (K.S.R.)apoptotic Jurkat T lymphocytes were fed to J774 murine
macrophage cells, and the distribution of dansyl-
cholesterol within the phagocyte was monitored via
fluorescence microscopy (Figure 1A). Engagement of
the apoptotic corpse and its internalization by the J774
cells was complete by w30 min. Breakdown of the
corpse began by 1 hr with distribution of the dansyl-
cholesterol throughout the macrophage over the sub-
sequent 8–10 hr. By 10 hr, dansyl-cholesterol was dif-
fusely distributed throughout the macrophage. We also
used 3H-cholesterol-labeled apoptotic Jurkat cells to
examine the distribution/efflux of apoptotic cell-derived
cholesterol by the phagocyte. Again, we observed no
preferential loss/efflux of the labeled apoptotic cell-
derived cholesterol by the J774 cells after engulfment
(data not shown). Thus, the cholesterol derived from
the apoptotic cells appeared to become part of the cho-
lesterol pool of the phagocyte.
Stimulation of Enhanced Cholesterol Efflux
from Macrophages by Apoptotic Cells
Since the uptake of apoptotic cell-derived cholesterol
could potentially double the cholesterol content within
the engulfing macrophage (or triple or quadruple the
cholesterol content when macrophages take up multiple
apoptotic cells [7]), we asked whether the basal choles-
terol efflux from the phagocyte might be enhanced as
a possible homeostatic response to lower the choles-
terol load. Cholesterol efflux can proceed through the
ATP binding cassette (ABC) transporter ABCA1 via apo-
lipoprotein A-I (apoA-I) as an acceptor, or through a non-
specific mechanism (possibly involving ABCG1) to high-
density lipoprotein (HDL). J774 cells were loaded with
3H-cholesterol and then incubated with apoptotic Jurkat
cells (denoted AJ). After the unengulfed AJ were washed
away, HDL- or apoA-I-mediated cholesterol efflux was
measured [8]. Addition of apoptotic Jurkat cells resulted
in a reproducible increase in the basal cholesterol efflux
to apoA-I (1.9-fold, p < 0.01, n = 8) (Figure 1B). In con-
trast, we observed no significant increase in cholesterol
efflux to HDL (data not shown). In a time course of the
efflux assay with apoA-I, the enhanced cholesterol efflux
by the phagocyte was induced as early as 1–2 hr postin-
cubation with apoptotic cells, peaked by about 4–6 hr
(Figure 1B) and was similar to basal efflux by 10 hr
(data not shown). This suggested that apoptotic cells in-
duce a transient increase in the basal phagocyte choles-
terol efflux to apoA-I. The percent efflux reported here is
likely an underestimation of the efflux stimulated in the
engulfing macrophages, since under these assay condi-
tions only about 20% of the macrophages engulf the
apoptotic cells but the efflux is measured over all the
macrophages in the population. It is noteworthy that
the percent efflux observed (w2%–15% in various ex-
periments) is similar to that stimulated by agonists
such as phorbol esters from macrophages in our hands
[8]. This enhanced cholesterol efflux to apoA-I resulting
from addition of apoptotic cells was not a unique
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2253Figure 1. Engulfment of Apoptotic Cells, but Not Necrotic Cells, Leads to Enhanced Phagocyte Cholesterol Efflux
(A) Distribution of cholesterol derived from an apoptotic corpse within the J774 macrophages. Apoptotic Jurkat T cells labeled with dansyl-
cholesterol were incubated with J774 macrophages. The engulfment and processing of apoptotic cell-derived cholesterol was monitored
from 30 min to 10 hr by following the fluorescence of dansyl cholesterol by fluorescence microscopy. The images are representative of multiple
cells in the field in the individual time points and at least two independent experiments. 42 out of 50 cells analyzed (84%) exhibited the fluores-
cence pattern demonstrated here.
(B) J774 macrophages were prelabeled with 3H-cholesterol and incubated with apoptotic Jurkat (AJ), washed, and then incubated with or with-
out apoA-I. The apoA-I-specific 3H-cholesterol efflux into the supernatant was calculated and expressed as the percentage of total radioactivity
(cells plus medium). Each experimental condition was performed in quadruplicate, and mean (6SD) from a representative experiment out of four
independent experiments is shown. Asterisk indicates significant difference compared to control.
(C) Enhancement of cholesterol efflux is specific for engagement of engulfment receptors. 3H-cholesterol efflux from J774 cells was measured as
above after incubation with apoptotic cells and Annexin V, anti-CD3-coated apoptotic Jurkat cells (to facilitate uptake via Fc receptor-mediated
phagocytosis) or necrotic cells. Each experimental condition was performed in quadruplicate, and mean (6SD) from a representative experiment
out of three independent experiments is shown. Asterisk indicates significant difference for the AJ condition compared to control.property of J774 cells, and was seen in primary macro-
phages as well as fibroblasts (see below).
In contrast to apoptotic Jurkat cells, addition of
necrotic Jurkat cells (denoted NJ) did not increase the
basal cholesterol efflux from the J774 cells (Figure 1C).
As assessed by microscopy, the necrotic Jurkat cells
were taken up and the cholesterol derived from them
distributed within the phagocyte (see Figure S1A in the
Supplemental Data available online). We also tested
apoptotic Jurkat cells that were coated with a CD3 anti-
body [7], to allow Fc-receptor-mediated uptake. Inter-
estingly, these antibody-coated apoptotic Jurkat cells
failed to augment the basal cholesterol efflux (Figure 1C),
although these targets were taken up and their choles-
terol derived from them distributed within the phagocyte
(Figure S1B). The lack of an increase in cholesterol efflux
in phagocytes after incubation with necrotic cells or
antibody-coated apoptotic cells was not due to a de-
layed kinetics of efflux (Figure 1C). We derived two im-
portant insights from the above data. First, apoptotic
cells specifically induce a cholesterol efflux from phago-
cytes, whereas necrotic or opsonized corpses do not.
Second, surprisingly, it is the route of entry of the
apoptotic cells into macrophages (via engulfmentreceptors), rather than the simple increase in phagocyte
total cholesterol content per se, that appears critical for
stimulating an enhanced cholesterol efflux response
from the phagocytes.
Surrogate Apoptotic Targets
and Phosphatidylserine Vesicles Can Enhance
Cholesterol Efflux from Macrophages
We next asked whether a surrogate apoptotic target
that does not contain any cholesterol would also stimu-
late increased cholesterol efflux. We and others have
previously used 2 mm carboxylate-modified polystyrene
beads [9, 10] as an artificial target whose negative charge
and other characteristics appear to mimic features on
apoptotic cells (including blockage of their uptake by
Annexin V and the requirement for specific signaling
molecules within the phagocyte for their uptake). Re-
markably, addition of these surrogate targets signifi-
cantly enhanced cholesterol efflux from J774 cells (1.7-
fold, p < 0.02, n = 8) (Figure 2A). Consistent with the
lack of CD3 on their cell surface, the cholesterol efflux
induced by these beads was not inhibited by addition
of CD3 antibodies (as with apoptotic Jurkat cells)
(Figure 2A). Thus, the enhanced phagocyte cholesterol
Current Biology
2254Figure 2. Surrogate Targets or Phosphatidylserine Microbubbles Stimulate Cholesterol Efflux from J774 Cells and Primary Human Macrophages
(A) J774 macrophages were incubated with apoptotic Jurkat cells, necrotic Jurkat cells, 2 mm carboxylate-modified beads (surrogate targets), or
PS-containing microbubbles. After 4 hr, apoA-I-specific 3H-cholesterol efflux was calculated as in Figure 1B. In some cases, after the initial in-
cubation with apoptotic cells or necrotic cells and washing away unengulfed targets, the PS bubbles were added and then the efflux response
was measured. Each experimental condition was performed in quadruplicate, and mean (6SD) from a representative experiment out of three
independent experiments is shown. Asterisk indicates significant difference compared to control.
(B) Monocyte-derived macrophages (MDM) from two different normo-lipidemic control subjects were isolated and cultured as previously
described [25]. An efflux assay on these macrophages was performed after addition of apoptotic Jurkat cells, necrotic Jurkat cells, surrogate
beads, PS bubbles, AJ followed by PS bubbles, and NJ followed by PS bubbles. Each individual experimental condition was performed in qua-
druplicate and the efflux displayed as mean (6SD) from two independent normo-lipidemic subjects. Asterisk indicates significant difference
compared to control.
(C) Receptor associated protein (RAP) inhibits enhanced cholesterol efflux induced by apoptotic targets. AJ or surrogate targets were incubated
with J774 macrophages or LR73 CHO cells in the presence or absence of the LRP1 ligand and competitive inhibitor RAP (10 mg). After 4 hr, apoA-I
specific 3H-cholesterol efflux was calculated as above. Each individual experimental condition was performed in triplicate and displayed as
mean (6SD), and a representative experiment (out of three independent experiments) is presented here.efflux appeared to be an early homeostatic response,
stimulated only by recognition of apoptotic markers on
targets, prior to the entry of the apoptotic cell-derived
cholesterol.
PS-Dependent Stimulation of Cholesterol
Efflux from Macrophages
While multiple ligands on apoptotic cells have been de-
scribed, the exposure of phosphatidylserine (PS) on the
outer leaflet of the plasma membrane of apoptotic cells
(normally found on the inner side) is a key ‘‘eat-me’’ sig-
nal recognized by phagocytes [1, 2]. We tested the
potential importance of recognizing PS on apoptotic
cells for the induction increased cholesterol efflux from
J774 cells. Addition of Annexin V to block the phagocyte
recognition of PS on apoptotic Jurkat cells inhibited
enhancement of cholesterol efflux in the J774 cells (Fig-
ure 1C). To more directly test a role for PS, we added
phosphatidylserine-containing microbubbles to J774
cells. Addition of 2 mm gas-filled PS bubbles (15%PS: 85% PC) stimulated cholesterol efflux from J774
cells (Figure 2A). Similarly, PS-containing phospholipid
vesicles (10% PS: 90% PC) also stimulated efflux, while
vesicles containing PC alone did not (see below).
This PS-dependent efflux response was not unique
to murine J774 macrophage cells, since human blood
monocyte-derived macrophages, generated from two
different healthy individuals, showed a similar choles-
terol efflux in response to apoptotic cells. Moreover,
these primary macrophages had similar enhanced efflux
response to surrogate apoptotic targets and PS bub-
bles, but not to necrotic cells (Figure 2B). Since PS is
also exposed on necrotic cells, but the necrotic cells
do not induce an enhanced efflux response from macro-
phages, either PS exposed on necrotic cells fail to stim-
ulate PS-recognizing receptors on phagocytes or the
necrotic cells may stimulate additional receptors that
counter the enhanced efflux. Intriguingly, simultaneous
addition of PS bubbles or surrogate apoptotic targets
with necrotic cells did stimulate an enhanced efflux
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2B and Figure S2). This suggested that necrotic cells
perhaps fail to stimulate appropriate engulfment recep-
tors to mediate the enhanced cholesterol efflux. Taken
together, these data suggest that engagement of PS-
recognizing receptors on phagocytes can stimulate
cholesterol efflux from murine and human macrophages.
Potential Role of LRP1 in Regulating Cholesterol
Efflux by Apoptotic Targets
At present, multiple phagocyte engulfment receptors
and bridging molecules have been linked to recognition
of PS on apoptotic cells [1, 2]. A recent report suggested
a model that PS on the apoptotic cell surfaces is colocal-
ized with the protein Calreticulin and that they coopera-
tively provide ligands that stimulate engulfment [7]. Cal-
reticulin on apoptotic cell surfaces is recognized by the
low-density lipoprotein receptor-related protein 1 (LRP-1)
[7, 11]. LRP1 has also been independently linked to cho-
lesterol regulation and atherosclerosis in humans and
mice [12, 13] and is a candidate homolog of the C. ele-
gans engulfment gene CED-1 [14]. We tested whether
LRP1 might play a role in regulating cholesterol efflux
induced by apoptotic cells. Receptor-associated pro-
tein (RAP) is a ligand for LRP1, and addition of soluble
RAP can inhibit engulfment of apoptotic cells [7]. Addi-
tion of RAP inhibited the enhanced efflux in J774 macro-
phages and LR73 fibroblasts induced by apoptotic
Jurkat cells and surrogate apoptotic targets (Figure 2C).
This correlated with the ability of RAP to inhibit apopto-
tic cell uptake (Figure S3). Since a soluble LRP1 ligand
a2-macroglobulin did not stimulate efflux from these
cells (data not shown), signaling via LRP1 alone might
not be sufficient for the enhanced efflux, but rather
LRP1 along with other receptor(s) potentially mediates
recognition of apoptotic cell surfaces necessary to trig-
ger an enhanced cholesterol efflux.
Upregulation of ABCA1 within Macrophages
by Apoptotic Cell Recognition
We then addressed the mechanism by which apoptotic
cells may induce increased cholesterol efflux from
phagocytes. ABCA1 mediates apoA-I-dependent cho-
lesterol efflux, and loss of ABCA1 in humans leads to
Tangier disease, a disorder characterized by very low
plasma HDL levels [4]. ABCA1 is also linked to apoptotic
cell clearance in mammals [3], although the precise func-
tion of ABCA1 during engulfment remains unclear [15].
We examined the requirement of ABCA1 in cholesterol
efflux induced by apoptotic targets by using primary
bone marrow-derived macrophages (BMDM) generated
from ABCA1-deficient mice [16]. While addition of apo-
ptotic targets enhanced the basal cholesterol efflux
in BMDM obtained from wild-type mice, ABCA12/2
BMDM efflux showed no enhanced efflux after addition
of apoptotic targets (Figure 3A). It is noteworthy that
under these conditions, there was no significant increase
in HDL-dependent efflux (e.g., via ABCG1) (data not
shown). Thus, ABCA1 protein was essential for the en-
hanced cholesterol efflux induced by apoptotic targets.
We then tested whether mRNA and protein levels of
ABCA1 in the phagocytes are modified by apoptotic
cells, since ABCA1 protein level can be regulated by
alteration of cholesterol levels in macrophages [17].Real-time PCR showed an increase in abca1 message
in J774 cells at 4 and 6 hr after addition of apoptotic
cells, compared to necrotic cells (Figures 3B and 3C).
Consistent with this observation, ABCA1 protein level
was also increased by 4 hr after incubation with the
apoptotic cells and continued to increase up to 6 hr,
with a decrease by 10 hr (Figure 3D and data not shown).
This increase in ABCA1 protein level in J774 cells in-
duced by apoptotic cells was inhibited by addition of
Annexin V, suggesting an important role for PS-depen-
dent recognition in the upregulation of ABCA1 protein
levels in the macrophages (Figure 3E). Moreover, the
ABCA1 protein level was not increased by addition of
necrotic cells, or anti-CD3-coated apoptotic cells, and
correlated with their failure to promote phagocyte cho-
lesterol efflux (Figure 3E). Interestingly, addition of
2 mm carboxylate-modified beads also enhanced the
ABCA1 protein levels in phagocytes (Figure 3E), which
correlated with the ability of these beads to stimulate
cholesterol efflux. Thus, while the previous studies have
suggested that cellular sensing of higher intracellular
free cholesterol and oxysterol ligands is important in
regulating ABCA1 levels [17, 18], the above data suggest
that signaling downstream of engulfment receptors
could also regulate ABCA1 levels and thereby regulate
cholesterol efflux.
Role of Nuclear Receptors in Regulating Apoptotic
Cell-Induced ABCA1 Expression
Previous studies have suggested a key role for the
nuclear receptors PPARg and Liver X receptor (LXR) in
transcriptional regulation of cellular ABCA1 levels by
oxysterols and the subsequent ABCA1-dependent cho-
lesterol transport from cells [5]. There are at least two
pathways by which ABCA1 expression may be regu-
lated by LXR: either a direct activation of LXR by oxy-
sterols or the activation of PPARg receptors that in
turn regulate LXR to promote ABCA1 expression.
LXRa/b expression is readily detected in J774 cells,
while PPARg expression has been variably detected
[19, 20]. To test whether the nuclear receptors PPARg
and/or LXRa/b might play a role in apoptotic cell-
induced upregulation of ABCA1 levels, we used previ-
ously characterized antagonists of PPARg and LXR
that have been shown to inhibit signaling via these
nuclear receptors [18, 21]. Addition of the LXRa/b antag-
onist geranylgeraniol (denoted GG) stunted the choles-
terol efflux from macrophages induced by apoptotic
cells. Addition of the PPARg antagonist GW9662 also
inhibited the induction of cholesterol efflux stimulated
by apoptotic cells (Figure 4A), and the inhibition was
dose dependent (Figure S4). It is notable that the macro-
phages showed no defects in viability after the drug
treatments. This inhibition of cholesterol efflux by the
PPARg and LXR antagonist drugs correlated with their
ability to inhibit the upregulation of ABCA1 protein by
apoptotic cells (Figure 4A). The PPARg and LXRa/b
antagonists also inhibited the increased cholesterol
efflux stimulated by PS vesicles, suggesting that PS-
dependent engulfment signals that promote increased
cholesterol efflux require the functional activity of the
PPARg and LXR nuclear receptors (Figure 4B). Under
the same conditions, the addition of PPARg agonist
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2256Figure 3. ABCA1 mRNA and Protein Are Upregulated in J774 Cells after Incubation with Apoptotic Cells
(A) ABCA1-deficient primary macrophages fail to show enhanced cholesterol efflux after addition of apoptotic cells. ApoA1-dependent choles-
terol efflux assay was performed on ABCA1 wild-type and ABCA1-deficient bone marrow-derived macrophages. Each individual time point was
performed in quadruplicate, and a representative experiment out of two independent experiments is presented here. Asterisk indicates signif-
icant difference for the 4 hr time points with targets compared to control.
(B) J774 cells were either untreated or incubated for 6 hr with apoptotic Jurkat (AJ) or necrotic Jurkat (NJ) cells. Real-time PCR was performed in
duplicate with abca1-specific probes and normalized to gapdh levels. The increase in abca1 message levels are presented after considering the
value with untreated cells as 1.0. The average of two independent experiments6 SD is shown. Asterisk denotes significant difference for the AJ
condition compared to control.
(C) Same as in (B) above, except that the analysis was done in a time course, with 18S RNA as control and the increase with necrotic cells set at
1.0. Asterisk indicates significant difference for addition of apoptotic cell condition compared to necrotic cell condition for the 4 and 6 hr time
points.
(D) J774 cells were incubated with apoptotic Jurkat cells, and after washing off unbound cells, ABCA1 protein expression in the J774 cells was
assessed in a time course by western blotting. Stripping and reprobing of the membrane for Calnexin was used to confirm comparable protein
loading. A representative blot out of two independent experiments is presented here.
(E) The upregulation of ABCA1 protein level in J774 cells was measured after incubation with apoptotic Jurkat cells, anti-CD3-coated apoptotic
cells, apoptotic cells incubated with Annexin V, necrotic cells, or surrogate targets. After washing off unbound targets, the ABCA1 protein
expression in J774 cells were measured after 4 hr as above. Stripping and reprobing of the membrane for Calnexin was used to confirm com-
parable protein loading. A representative blot out of two independent experiments is presented here.rosiglitizone, or the LXR agonists TO901317 or 22(R)-hy-
droxycholesterol, stimulated ABCA1 expression consis-
tent with previously published reports (data not shown)
[17]. Taken together, these data suggested that the in-
creased ABCA1 expression induced by PS-dependent
recognition of apoptotic cells and the increase choles-
terol efflux likely involve the nuclear receptors LXR and
PPARg that have been previously linked to regulation of
ABCA1 expression under other conditions. It is unclear
how the engulfment receptors communicate with the
nuclear receptors. Although cholesterol loading of cells
or entry of oxysterols into the macrophages induce
ABCA1 upregulation and efflux [5, 17], the ability of sur-
rogate apoptotic targets with no cholesterol on their own
to stimulate ABCA1 expression suggests that signals
from the engulfment receptors leading to PPARg/LXR
activation might be more complex, and perhaps novel.A recent report described a model system of free-
cholesterol loading of macrophages to make them apo-
ptotic (denoted FC-AM) [22]. By using FC-AM as targets,
the authors were able to show an enhancement of
cholesterol efflux from other macrophages, through a
TNFa-mediated NF-kB-dependent mechanism. Since
other reports have shown that TNF and NF-kB inhibit
ABCA1 expression [23], and apoptotic cells can actively
suppress TNFa production in the phagocyte [24],
whether FC-AM might use different modalities remain
to be determined.
Our observations may also have relevance for the role
of macrophages in late-stage atherosclerotic lesions,
which contain apoptotic cells and a core of necrotic cells
[6]. The uptake of these necrotic cells and the failure to
stimulate efflux by the engulfing ‘‘healthy’’ macrophages
could potentially perpetuate the situation and promote
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2257Figure 4. Enhanced Phagocyte Cholesterol
Efflux Stimulated by Apoptotic Cells Requires
Function of Nuclear Receptors Linked to
Regulation of ABCA1 Expression
(A) J774 cells were preincubated with a
PPARg antagonist GW9662 (10 mM), PPARg
agonist rosiglitizone (100 nM), and LXRa/b -
antagonist geranylgeraniol (GG) (10 mM) for
16 hr. Apoptotic Jurkat cells were added in
the absence or presence of the above drugs,
unbound targets were washed, and apoA1-
dependent cholesterol efflux was measured
as indicated. Each individual experimental
condition was performed in quadruplicate
and a representative experiment out of three
independent experiments is presented here.
Asterisk indicates statistically significant
change compared to NJ condition. A western
blot of ABCA1 protein from the samples num-
bered according to the treatment conditions
above is also shown. Stripping and reprobing
of the membrane for Calnexin was used to
confirm comparable protein loading. A repre-
sentative blot out of two independent exper-
iments is presented here.
(B) The experiment similar to the above was
performed with PS vesicles or PC vesicles, and the cholesterol efflux by J774 cells was measured. Each individual experimental condition
was performed in quadruplicate and a representative experiment out of three independent experiments is presented here. Asterisk denotes
statistically significant change compared to the control condition.the appearance of cholesterol-laden macrophages
(‘‘foam cells’’). Interestingly, the addition of artificial tar-
gets that mimic apoptotic cells or PS microbubbles were
able to stimulate cholesterol efflux when added with ne-
crotic cells (Figures 2A and 2B and Figure S2). Thus, trig-
gering of specific engulfment receptors in a physiologi-
cal way to stimulate efflux from phagocytes might
provide a potential therapeutic alternative in the future
treatment of atherosclerosis.
In summary, these data reveal several features of a
homeostatic program triggered in phagocytes during
engulfment, including a proximal signaling event initi-
ated by recognition of PS on apoptotic cells, a down-
stream signaling event acting through nuclear receptors,
and an effector arm involving upregulation of the mem-
brane transporter ABCA1, in turn promoting cholesterol
efflux from the phagocytes. These data have important
implications for how a phagocyte might maintain ho-
meostasis in the face of incoming lipids and cholesterol
derived from the apoptotic cells and for disease states
such as atherosclerosis.
Supplemental Data
Supplemental Data include four figures and Supplemental Ex-
perimental Procedures and can be found with this article online at
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